Bioanalysis testing services
Ended Awarded Last action
- Contract number
- HHSN27100007
- Awardee
-
Pharmaron, Inc. UEI L8NQAFSTPSY9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $101,372
Award facts
- Opportunity
-
- 2015306 Solicitation number
- Sources Sought Notice - SCREWDRIVER, OFFSET, RATCHET, 1/4 inch SLOTTED, PHILLIPS #2 Award Notice · Posted Aug 21, 2015
- Contract value 100% obligated
- $101,372.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Louisville, KY 40202, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,228 | |
| Original award | $102,600 |
About this award
This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), to Pharmaron, Inc. The $101,372.00 firm fixed-price delivery order contract is part of the NIH Bioanalysis Testing Services 2015-2020 indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle. Under this award, Pharmaron will provide a range of preclinical research services to support NIDA's drug discovery and development initiatives, including pharmacokinetic assessments, toxicity studies, and ion channel testing. This contract does not have a set-aside designation. Pharmaron, a minority-owned, for-profit organization, has extensive expertise in preclinical research and has previously supported NIDA by conducting studies on potential therapies for metabolic disorders, cancer, and COVID-19. This contract award demonstrates Pharmaron's role as a key partner in advancing potential new treatments through the drug development pipeline.
Quick answers
Who was awarded contract HHSN27100007?
HHSN27100007 was awarded to Pharmaron, Inc. by National Institute on Drug Abuse (National Institutes of Health) on May 26, 2016.
How much is contract HHSN27100007 worth?
The government has obligated $101,372 on HHSN27100007.
Is contract HHSN27100007 an order under another contract?
Yes. HHSN27100007 is a delivery order under HHSN271201500025I, an indefinite delivery contract, on NIH Bioanalysis Testing Services 2015-2020.
Was contract HHSN27100007 competed?
The extent of competition for HHSN27100007 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award